Clinical Trials for Alzheimer Disease

Find clinical trials for alzheimer disease. Discover research opportunities and treatment options in your area.

477 Active Trials Found

Showing 477 trials on this page

Page 1 of 24

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

NCT ID: NCT05026866

The TRAILBLAZER-ALZ 3 study is a clinical trial focused on testing the safety and effectiveness of a drug called donanemab in people who have early signs of Alzheimer's disease but do not yet have ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Los Angeles, California, United States, Elk Grove Village, Illinois, United States +311 more

A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

NCT ID: NCT06538116

This clinical trial is studying a new medication called mevidalen (LY3154207) to see if it is safe and effective for people with mild to moderate Alzheimer's disease. The goal is to find out if thi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Elk Grove Village, Illinois, United States, New Port Richey, Florida, United States +64 more

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

NCT ID: NCT06585787

The ADEPT-4 clinical trial is studying a new treatment called KarXT for individuals with Alzheimer's Disease (AD) who are experiencing psychosis, which includes symptoms like hallucinations or delu...

Recruiting

Phase: PHASE3 Type: interventional Locations: Columbus, Ohio, United States, Seoul, , Korea, Republic Of +507 more

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

NCT ID: NCT06657768

This clinical trial is investigating a new study drug called LY4006895 to see how safe it is and how well it works in people with early symptoms of Alzheimer's disease (AD) and healthy participants...

Recruiting

Phase: PHASE1 Type: interventional Locations: Atlanta, Georgia, United States, Maitland, Florida, United States +6 more

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

NCT ID: NCT06937229

The ADAGIO-3 study is a clinical trial focused on testing a new treatment for agitation in people with Alzheimer’s Disease. This trial will specifically look at the long-term effects and safety of ...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Athens, , Greece, Malaga, , Spain +197 more

[18F]PI-2620 Phase 3 Histopathological Study

NCT ID: NCT05641688

This clinical trial, called the [18F]PI-2620 Phase 3 Histopathological Study, is looking at a new imaging method using a special PET scan to detect tau protein in the brains of people with Alzheime...

Recruiting

Phase: PHASE3 Type: interventional Locations: Phoenix, Arizona, United States, Dallas, Texas, United States +25 more

Olfactory Biopsies

NCT ID: NCT07021040

This clinical trial, called "Olfactory Biopsies," is looking into how the sense of smell works and whether it changes in people with Alzheimer’s disease and other conditions. The researchers want t...

Recruiting

Phase: NA Type: interventional Locations: Durham, North Carolina, United States

HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

NCT ID: NCT06930560

The HEARS-NPS trial is a study focused on helping older adults with Alzheimer’s Disease and related dementias who also have hearing loss. This trial will test a special hearing care program designe...

Not yet recruiting

Phase: NA Type: interventional

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

NCT ID: NCT07011732

The ADAGIO-1 clinical trial is a study looking at a new treatment called KarXT combined with KarX-EC for adults experiencing agitation due to Alzheimer’s disease. Agitation can include feelings of ...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Brasília, Distrito Federal, Brazil, Curitiba, Paraná, Brazil +220 more

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)

NCT ID: NCT07011745

This clinical trial, called ADAGIO-2, is investigating a new treatment called KarXT + KarX-EC for adults with Alzheimer's disease who experience agitation. Agitation can include feelings of restles...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Seoul, , Korea, Republic Of, Brno, Jihomoravský Kraj, Czechia +213 more

Swallowing Impairments in Adults With and Without Alzheimer's Disease

NCT ID: NCT06678100

This clinical trial is studying how swallowing abilities change in adults with Alzheimer's disease (AD) compared to healthy older adults. Researchers want to learn more about swallowing difficultie...

Recruiting

Type: observational Locations: Nashville, Tennessee, United States

A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)

NCT ID: NCT06721156

This clinical trial is studying a new medicine called MK-1167 to see if it can help improve memory and thinking skills in people with Alzheimer's disease dementia. Alzheimer's disease is the most c...

Recruiting

Phase: PHASE2 Type: interventional Locations: Naples, Florida, United States, Sherman Oaks, California, United States +62 more

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

NCT ID: NCT05508789

The TRAILBLAZER-ALZ 5 trial is studying a medication called donanemab to see if it can help people with early symptoms of Alzheimer’s disease. The goal is to find out how safe the medication is and...

Recruiting

Phase: PHASE3 Type: interventional Locations: Box Hill, Victoria, Australia, Parkville, Victoria, Australia +290 more

A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

NCT ID: NCT06881836

This clinical trial is studying a new medication called ONO-2020 to see if it can help improve memory and thinking skills in people with mild to moderate Alzheimer's disease. It is a Phase 2 study,...

Recruiting

Phase: PHASE2 Type: interventional Locations: New Port Richey, Florida, United States, Delray Beach, Florida, United States +37 more

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

NCT ID: NCT06808984

This clinical trial is looking at a new medication called BMS-986368, which aims to help reduce agitation in people with Alzheimer's disease. Agitation can include feelings of restlessness, irritab...

Recruiting

Phase: PHASE2 Type: interventional Locations: Maitland, Florida, United States, Atlanta, Georgia, United States +45 more

The BRAIN App (Phase 2 SBIR)

NCT ID: NCT06298474

The BRAIN App clinical trial is studying a new digital tool designed to help improve the lives of people living with dementia, including Alzheimer’s and vascular dementia. This innovative app uses ...

Recruiting

Phase: NA Type: interventional Locations: Winchester, Massachusetts, United States

Effects and Mechanisms of Temporal Interference Brain Stimulation on Memory Function in Preclinical Alzheimer's Disease

NCT ID: NCT07031687

This clinical trial is exploring a new type of brain stimulation called Temporal Interference Brain Stimulation (TIBS) to see if it can help improve memory in people who are in the very early stage...

Recruiting

Phase: NA Type: interventional Locations: Beijing, , China, Sanya, Hainan, China

Choline Effects - Pre-symptomatic AD

NCT ID: NCT05880849

This clinical trial, called "Choline Effects - Pre-symptomatic AD," is exploring the safety and effects of a dietary supplement called choline in people who are at higher risk for developing Alzhei...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

The COMFORTage Project at Ace Alzheimer Center Barcelona

NCT ID: NCT07031167

The COMFORTage study at Ace Alzheimer Center Barcelona is looking at whether a special program of personalized mental and physical activities can help slow down memory loss and thinking problems in...

Not yet recruiting

Phase: NA Type: interventional Locations: Barcelona, , Spain

Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease

NCT ID: NCT05904132

This clinical trial is investigating a new treatment approach for people with mild cognitive impairment (MCI) that may be related to Alzheimer’s disease. The study will use a method called closed-l...

Recruiting

Phase: NA Type: interventional Locations: Charlestown, Massachusetts, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions